Triamcinolone also had similar effectiveness when compared with grid laser for macular edema in BRVO.8,9 Ranibizumab, bevacizumab, and aflibercept as anti-VEGF agents, and steroids, especially dexamethasone (DEX) implants, are widely used in patients with RVO, marking a new epoch in the pharmacotherapy of macular edema via triamcinolone. Here, VEGFA is linked to macular retinal edema.